Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000432 · ClinicalTrials.gov registry record · Phase 3
Lyme Disease Prevention Program
A Phase 3 study of Lyme Disease and Tick-borne Diseases, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 20,000
- Enrollment target
- 1
- Study location
NCT00000432: Completed Phase 3 study of Lyme Disease and Tick-borne Diseases, sponsored by Brigham and Women's Hospital.
NCT00000432 is a Phase 3 study of Lyme Disease and Tick-borne Diseases that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20,000 participants, above the 1,652-participant average among 9 other Lyme Disease trials with a reported enrollment target (1111% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000432, a Phase 3 study of Lyme Disease and Tick-borne Diseases, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a large study of an educational program on Lyme disease prevention for passengers on ferry boats going to Nantucket Island during the period from Memorial Day until Labor Day. Some boats provide passengers with the experimental program and the other boats provide a "control" program that the researchers can compare to the experimental program. The experimental program uses live performances by entertainers to teach people about Lyme disease prevention, and also uses additional printed materials. People on the control boats receive education on injury prevention and road safety while bicycling, rollerblading, and using mopeds. The main result we will look for is Lyme disease identified by a followup survey and confirmed by reviewing medical records. We will also ask some people to take part in a smaller study of behavior change. In this study, we will ask people to complete forms on self-efficacy (a person's belief in his or her ability to reach a certain goal), their plans to take preventive steps, and actual prevention behaviors. We also ask participants who report doctor visits or illness to provide confirmation of their use of health services.
Conditions Studied
Interventions
- BEHAVIORAL Education about disease prevention
Study Locations (1)
Massachusetts
- Steamship Authority ferry boats to Nantucket Island - Hyannis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 1997-04 |
| Est. Completion | 2001-03 |
| Phase | Phase 3 |
What the finished NCT00000432 record still lists
NCT00000432 is an interventional study that assigns participants to a tested intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,652-participant average among 9 other Lyme Disease trials with a reported enrollment target (1111% higher).
The record links to 2 conditions, with Lyme Disease appearing as the primary indexed condition, and to 1 intervention - of which Education about disease prevention is the first listed.
NCT00000432 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00000432 about?
NCT00000432 is a clinical study titled "Lyme Disease Prevention Program". This is a large study of an educational program on Lyme disease prevention for passengers on ferry boats going to Nantucket Island during the period from Memorial Day until Labor Day. Some boats provide passengers with the experimental program and the other boats provide a "control" program that the...
What is the current status of trial NCT00000432?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20,000 participants. The study started on 1997-04. Estimated completion is 2001-03.
What conditions does trial NCT00000432 study?
This clinical trial studies the following conditions: Lyme Disease, Tick-borne Diseases.
What interventions are being tested in trial NCT00000432?
The interventions under investigation include: Education about disease prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000432?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000432 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lyme Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00000432's enrollment target sits among peer trials
20,000 1st of 9 higher than 9 of 9 other Lyme Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lyme Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
ACTIVE NOT RECRUITING · Phase 3
-
Study and Treatment of Post Lyme Disease (STOP-LD)
COMPLETED · Phase 3
-
Human Immune Response to Ixodes Scapularis Tick Bites
RECRUITING · Phase 1
-
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
RECRUITING
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
RECRUITING
-
Navigating Pregnancy and Parenthood With Lyme Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia